Slingshot Insights | Biocon Ltd. Overview

BIOCON LTD. Overview

Upcoming Projects (BIOCON LTD.)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (BIOCON LTD.)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (BIOCON LTD.)

FDA Action Date of September 3rd for Mylan (MYL) and Biocon's Biologics License Application (BLA) For MYL-14010, a Biosimilar to Roche's (RHHBY) Breast Cancer Med Herceptin
Tickers: MYL, RHHBY, Biocon Ltd.
Occurred on: Jul 13, 2017
Mylan (MYL) and Biocon Submit Biologics License Application (BLA) to FDA for Biosimilar to Roche's (RHHBY) Herceptin for HER2-Positive Breast and Gastric Cancers
Tickers: MYL, RHHBY, Biocon Ltd.
Occurred on: Nov 08, 2016

Strategic Initiatives (BIOCON LTD.)

Don’t see a strategic initiative related to the company you care about? Create your own!